Profusa, Inc.

Profusa, Inc., listed under the ticker NVAC, is a life sciences and medical technology company focused on implantable biosensor technology designed for continuous, real-time monitoring of biological analytes such as oxygen and other metabolic markers. The company operates in the biotech and medical device sector and reached public markets through a SPAC transaction. Profusa filed its most recent Form 10-Q with the SEC on June 13, 2025, under accession number 0001213900-25-054386, reflecting its current status as an active public reporting company. Its proprietary Lumee biosensor platform targets both clinical and consumer health applications. Sign up at SpacDesk for full filing history, deal documents, and structured data on NVAC.